ÿþ<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"> <head> <meta http-equiv=Content-Type content="text/html; charset=unicode"> <meta name=ProgId content=Word.Document> <meta name=Generator content="Microsoft Word 12"> <meta name=Originator content="Microsoft Word 12"> <link rel=File-List href="publi_files/filelist.xml"> <link rel=Edit-Time-Data href="publi_files/editdata.mso"> <!--[if !mso]> <style> v\:* {behavior:url(#default#VML);} o\:* {behavior:url(#default#VML);} w\:* {behavior:url(#default#VML);} .shape {behavior:url(#default#VML);} </style> <![endif]--> <title>V. Wee Yong Lab</title> <!--[if gte mso 9]><xml> <o:DocumentProperties> <o:Author>Tex</o:Author> <o:LastAuthor>Tex</o:LastAuthor> <o:Revision>3</o:Revision> <o:TotalTime>11</o:TotalTime> <o:Created>2012-02-20T03:06:00Z</o:Created> <o:LastSaved>2012-02-20T03:21:00Z</o:LastSaved> <o:Pages>4</o:Pages> <o:Words>2843</o:Words> <o:Characters>16211</o:Characters> <o:Lines>135</o:Lines> <o:Paragraphs>38</o:Paragraphs> <o:CharactersWithSpaces>19016</o:CharactersWithSpaces> <o:Version>12.00</o:Version> </o:DocumentProperties> </xml><![endif]--> <link rel=themeData href="publi_files/themedata.thmx"> <link rel=colorSchemeMapping href="publi_files/colorschememapping.xml"> <!--[if gte mso 9]><xml> <w:WordDocument> <w:SpellingState>Clean</w:SpellingState> <w:GrammarState>Clean</w:GrammarState> <w:TrackMoves>false</w:TrackMoves> <w:TrackFormatting/> <w:ValidateAgainstSchemas/> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF/> <w:LidThemeOther>EN-US</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript> <w:Compatibility> <w:BreakWrappedTables/> <w:SnapToGridInCell/> <w:WrapTextWithPunct/> <w:UseAsianBreakRules/> <w:DontGrowAutofit/> <w:SplitPgBreakAndParaMark/> <w:DontVertAlignCellWithSp/> <w:DontBreakConstrainedForcedTables/> <w:DontVertAlignInTxbx/> <w:Word11KerningPairs/> <w:CachedColBalance/> </w:Compatibility> <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel> <m:mathPr> <m:mathFont m:val="Cambria Math"/> <m:brkBin m:val="before"/> <m:brkBinSub m:val="&#45;-"/> <m:smallFrac m:val="off"/> <m:dispDef/> <m:lMargin m:val="0"/> <m:rMargin m:val="0"/> <m:defJc m:val="centerGroup"/> <m:wrapIndent m:val="1440"/> <m:intLim m:val="subSup"/> <m:naryLim m:val="undOvr"/> </m:mathPr></w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true" DefSemiHidden="true" DefQFormat="false" DefPriority="99" LatentStyleCount="267"> <w:LsdException Locked="false" Priority="0" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Normal"/> <w:LsdException Locked="false" Priority="9" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="heading 1"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/> <w:LsdException Locked="false" Priority="39" Name="toc 1"/> <w:LsdException Locked="false" Priority="39" Name="toc 2"/> <w:LsdException Locked="false" Priority="39" Name="toc 3"/> <w:LsdException Locked="false" Priority="39" Name="toc 4"/> <w:LsdException Locked="false" Priority="39" Name="toc 5"/> <w:LsdException Locked="false" Priority="39" Name="toc 6"/> <w:LsdException Locked="false" Priority="39" Name="toc 7"/> <w:LsdException Locked="false" Priority="39" Name="toc 8"/> <w:LsdException Locked="false" Priority="39" Name="toc 9"/> <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/> <w:LsdException Locked="false" Priority="10" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Title"/> <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/> <w:LsdException Locked="false" Priority="11" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/> <w:LsdException Locked="false" Priority="22" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Strong"/> <w:LsdException Locked="false" Priority="20" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/> <w:LsdException Locked="false" Priority="59" SemiHidden="false" UnhideWhenUsed="false" Name="Table Grid"/> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/> <w:LsdException Locked="false" Priority="1" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 1"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 1"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 1"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/> <w:LsdException Locked="false" Priority="34" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/> <w:LsdException Locked="false" Priority="29" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Quote"/> <w:LsdException Locked="false" Priority="30" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 1"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 1"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 2"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 2"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 2"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 2"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 2"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 3"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 3"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 3"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 3"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 3"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 4"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 4"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 4"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 4"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 4"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 5"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 5"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 5"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 5"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 5"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 6"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 6"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 6"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 6"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 6"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/> <w:LsdException Locked="false" Priority="19" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/> <w:LsdException Locked="false" Priority="21" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/> <w:LsdException Locked="false" Priority="31" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/> <w:LsdException Locked="false" Priority="32" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/> <w:LsdException Locked="false" Priority="33" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Book Title"/> <w:LsdException Locked="false" Priority="37" Name="Bibliography"/> <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/> </w:LatentStyles> </xml><![endif]--> <link rel=Stylesheet type="text/css" media=all href=style1.css> <style> <!-- /* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;} @font-face {font-family:Tahoma; panose-1:2 11 6 4 3 5 4 4 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-520081665 -1073717157 41 0 66047 0;} @font-face {font-family:Times; panose-1:2 2 6 3 5 4 5 2 3 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536859905 -1073711039 9 0 511 0;} @font-face {font-family:Verdana; panose-1:2 11 6 4 3 5 4 4 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-1593833729 1073750107 16 0 415 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; color:black;} h1 {mso-style-priority:9; mso-style-unhide:no; mso-style-qformat:yes; mso-style-link:"Heading 1 Char"; mso-margin-top-alt:auto; margin-right:0in; mso-margin-bottom-alt:auto; margin-left:0in; mso-pagination:widow-orphan; mso-outline-level:1; font-size:24.0pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; color:black; font-weight:bold;} p.MsoBodyText, li.MsoBodyText, div.MsoBodyText {mso-style-priority:99; mso-style-link:"Body Text Char"; margin-top:0in; margin-right:-.3in; margin-bottom:0in; margin-left:0in; margin-bottom:.0001pt; text-align:justify; mso-pagination:none; tab-stops:.3in .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:char; font-size:12.0pt; mso-bidi-font-size:10.0pt; font-family:"Times","serif"; mso-fareast-font-family:"Times New Roman"; mso-bidi-font-family:"Times New Roman"; color:windowtext;} p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2 {mso-style-noshow:yes; mso-style-priority:99; mso-style-link:"Body Text 2 Char"; margin-top:0in; margin-right:-.3in; margin-bottom:0in; margin-left:0in; margin-bottom:.0001pt; text-align:justify; mso-pagination:none; tab-stops:.3in .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:char; font-size:12.0pt; mso-bidi-font-size:10.0pt; font-family:"Times","serif"; mso-fareast-font-family:"Times New Roman"; mso-bidi-font-family:"Times New Roman"; color:windowtext;} a:link, span.MsoHyperlink {mso-style-noshow:yes; mso-style-priority:99; color:blue; font-weight:bold; text-decoration:underline; text-underline:single;} a:visited, span.MsoHyperlinkFollowed {mso-style-noshow:yes; mso-style-priority:99; color:purple; font-weight:bold; text-decoration:underline; text-underline:single;} p {mso-style-priority:99; mso-margin-top-alt:auto; margin-right:0in; mso-margin-bottom-alt:auto; margin-left:0in; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; color:black;} p.MsoAcetate, li.MsoAcetate, div.MsoAcetate {mso-style-noshow:yes; mso-style-priority:99; mso-style-link:"Balloon Text Char"; margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:8.0pt; font-family:"Tahoma","sans-serif"; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; color:black;} p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph {mso-style-priority:34; mso-style-unhide:no; mso-style-qformat:yes; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:.5in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:"Times New Roman"; color:windowtext;} span.BodyTextChar {mso-style-name:"Body Text Char"; mso-style-priority:99; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Body Text"; mso-ansi-font-size:12.0pt; mso-bidi-font-size:12.0pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; color:black;} p.msobodytext1, li.msobodytext1, div.msobodytext1 {mso-style-name:msobodytext1; mso-style-unhide:no; margin-top:0in; margin-right:-.3in; margin-bottom:0in; margin-left:0in; margin-bottom:.0001pt; text-align:justify; mso-pagination:none; tab-stops:.3in .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:char; font-size:12.0pt; mso-bidi-font-size:10.0pt; font-family:"Times","serif"; mso-fareast-font-family:"Times New Roman"; mso-bidi-font-family:"Times New Roman"; color:windowtext;} span.BodyText2Char {mso-style-name:"Body Text 2 Char"; mso-style-noshow:yes; mso-style-priority:99; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Body Text 2"; mso-ansi-font-size:12.0pt; mso-bidi-font-size:12.0pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; color:black;} p.bodytext, li.bodytext, div.bodytext {mso-style-name:bodytext; mso-style-unhide:no; margin-top:0in; margin-right:0in; mso-margin-bottom-alt:auto; margin-left:0in; line-height:15.0pt; mso-pagination:widow-orphan; font-size:8.5pt; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-bidi-font-family:"Times New Roman";} p.pagename, li.pagename, div.pagename {mso-style-name:pagename; mso-style-unhide:no; mso-margin-top-alt:auto; margin-right:0in; mso-margin-bottom-alt:auto; margin-left:0in; line-height:18.0pt; mso-pagination:widow-orphan; font-size:13.5pt; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-bidi-font-family:"Times New Roman";} p.subheader, li.subheader, div.subheader {mso-style-name:subheader; mso-style-unhide:no; mso-margin-top-alt:auto; margin-right:0in; mso-margin-bottom-alt:auto; margin-left:0in; line-height:12.0pt; mso-pagination:widow-orphan; font-size:7.5pt; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-bidi-font-family:"Times New Roman"; font-weight:bold;} p.quote, li.quote, div.quote {mso-style-name:quote; mso-style-unhide:no; mso-margin-top-alt:auto; margin-right:0in; mso-margin-bottom-alt:auto; margin-left:0in; line-height:22.5pt; mso-pagination:widow-orphan; font-size:15.0pt; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-bidi-font-family:"Times New Roman";} p.smalltext, li.smalltext, div.smalltext {mso-style-name:smalltext; mso-style-unhide:no; mso-margin-top-alt:auto; margin-right:0in; mso-margin-bottom-alt:auto; margin-left:0in; mso-pagination:widow-orphan; font-size:7.5pt; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-bidi-font-family:"Times New Roman";} p.navtext, li.navtext, div.navtext {mso-style-name:navtext; mso-style-unhide:no; mso-margin-top-alt:auto; margin-right:0in; mso-margin-bottom-alt:auto; margin-left:0in; line-height:12.0pt; mso-pagination:widow-orphan; font-size:8.5pt; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-bidi-font-family:"Times New Roman"; color:black;} p.style2, li.style2, div.style2 {mso-style-name:style2; mso-style-unhide:no; mso-margin-top-alt:auto; margin-right:0in; mso-margin-bottom-alt:auto; margin-left:0in; mso-pagination:widow-orphan; font-size:8.5pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; color:black;} span.pages {mso-style-name:pages; mso-style-unhide:no;} span.volume {mso-style-name:volume; mso-style-unhide:no;} span.Heading1Char {mso-style-name:"Heading 1 Char"; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Heading 1"; mso-ansi-font-size:14.0pt; mso-bidi-font-size:14.0pt; font-family:"Cambria","serif"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:major-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:major-fareast; mso-hansi-font-family:Cambria; mso-hansi-theme-font:major-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi; color:#365F91; mso-themecolor:accent1; mso-themeshade:191; font-weight:bold;} span.BalloonTextChar {mso-style-name:"Balloon Text Char"; mso-style-noshow:yes; mso-style-priority:99; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Balloon Text"; mso-ansi-font-size:8.0pt; mso-bidi-font-size:8.0pt; font-family:"Tahoma","sans-serif"; mso-ascii-font-family:Tahoma; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-hansi-font-family:Tahoma; mso-bidi-font-family:Tahoma; color:black;} span.src1 {mso-style-name:src1; mso-style-unhide:no; font-family:"Times New Roman","serif"; mso-ascii-font-family:"Times New Roman"; mso-hansi-font-family:"Times New Roman"; mso-bidi-font-family:"Times New Roman";} span.ti2 {mso-style-name:ti2; mso-style-unhide:no; mso-ansi-font-size:11.0pt; mso-bidi-font-size:11.0pt; font-family:"Times New Roman","serif"; mso-ascii-font-family:"Times New Roman"; mso-hansi-font-family:"Times New Roman"; mso-bidi-font-family:"Times New Roman";} span.SpellE {mso-style-name:""; mso-spl-e:yes;} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-size:10.0pt; mso-ansi-font-size:10.0pt; mso-bidi-font-size:10.0pt;} @page WordSection1 {size:8.5in 11.0in; margin:1.0in 1.0in 1.0in 1.0in; mso-header-margin:.5in; mso-footer-margin:.5in; mso-paper-source:0;} div.WordSection1 {page:WordSection1;} /* List Definitions */ @list l0 {mso-list-id:205020963; mso-list-type:hybrid; mso-list-template-ids:103465814 1453605004 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;} @list l0:level1 {mso-level-start-at:130; mso-level-tab-stop:67.5pt; mso-level-number-position:left; margin-left:67.5pt; text-indent:-.25in; mso-bidi-font-family:"Times New Roman";} @list l0:level2 {mso-level-tab-stop:1.0in; mso-level-number-position:left; text-indent:-.25in;} @list l0:level3 {mso-level-tab-stop:1.5in; mso-level-number-position:left; text-indent:-.25in;} @list l0:level4 {mso-level-tab-stop:2.0in; mso-level-number-position:left; text-indent:-.25in;} @list l0:level5 {mso-level-tab-stop:2.5in; mso-level-number-position:left; text-indent:-.25in;} @list l0:level6 {mso-level-tab-stop:3.0in; mso-level-number-position:left; text-indent:-.25in;} @list l0:level7 {mso-level-tab-stop:3.5in; mso-level-number-position:left; text-indent:-.25in;} @list l0:level8 {mso-level-tab-stop:4.0in; mso-level-number-position:left; text-indent:-.25in;} @list l0:level9 {mso-level-tab-stop:4.5in; mso-level-number-position:left; text-indent:-.25in;} ol {margin-bottom:0in;} ul {margin-bottom:0in;} --> </style> <!--[if gte mso 10]> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman","serif";} </style> <![endif]--><!--[if gte mso 9]><xml> <o:shapedefaults v:ext="edit" spidmax="2050"/> </xml><![endif]--><!--[if gte mso 9]><xml> <o:shapelayout v:ext="edit"> <o:idmap v:ext="edit" data="1"/> </o:shapelayout></xml><![endif]--> </head> <body bgcolor=white lang=EN-US link=blue vlink=purple style='tab-interval:.5in' alink="#FF0000"> <div class=WordSection1> <p class=MsoNormal><span style='mso-fareast-font-family:"Times New Roman"; mso-no-proof:yes'><img width=800 height=127 id="_x0000_i1025" src="pict/top2w.jpg" alt="V Wee yong lab calgary"></span><span style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p> <table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=1049 style='width:786.75pt;mso-cellspacing:0in;mso-yfti-tbllook:1184;mso-padding-alt: 0in 0in 0in 0in' id=navigation> <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'> <td width=149 valign=top style='width:111.75pt;padding:0in 0in 0in 0in'> <table class=MsoNormalTable border=0 cellpadding=0 style='mso-cellspacing: 1.5pt;mso-yfti-tbllook:1184'> <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'> <td width=100 style='width:75.0pt;border:none;border-bottom:solid #003366 1.5pt; padding:.75pt .75pt .75pt .75pt'> <p class=MsoNormal><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; mso-fareast-font-family:"Times New Roman";color:#003366'>&nbsp;<br> &nbsp;<o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:1'> <td width=145 style='width:108.75pt;border:none;border-bottom:solid #003366 1.5pt; padding:.75pt .75pt .75pt .75pt'> <p class=MsoNormal><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; mso-fareast-font-family:"Times New Roman";color:#003366'><a href="index.htm"><b><span style='color:#003366;letter-spacing:1.2pt;text-decoration:none;text-underline: none'>HOME</span></b></a><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:2'> <td width=145 style='width:108.75pt;border:none;border-bottom:solid #003366 1.5pt; padding:.75pt .75pt .75pt .75pt'> <p class=MsoNormal><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; mso-fareast-font-family:"Times New Roman";color:#003366'><a href="research.htm"><b><span style='color:#003366;letter-spacing:1.2pt; text-decoration:none;text-underline:none'>Research</span></b></a><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:3'> <td width=158 style='width:118.5pt;border:none;border-bottom:solid #003366 1.5pt; padding:.75pt .75pt .75pt .75pt'> <p class=MsoNormal><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; mso-fareast-font-family:"Times New Roman";color:#003366'><a href="wee_bio.htm"><b><span style='color:#003366;letter-spacing:1.2pt; text-decoration:none;text-underline:none'>Biography</span></b></a><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:4'> <td width=145 style='width:108.75pt;border:none;border-bottom:solid #003366 1.5pt; padding:.75pt .75pt .75pt .75pt'> <p class=MsoNormal><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; mso-fareast-font-family:"Times New Roman";color:#003366'><a href="tour.htm"><b><span style='color:#003366;letter-spacing:1.2pt;text-decoration:none;text-underline: none'>Tour of Lab</span></b></a><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:5'> <td width=145 style='width:108.75pt;border:none;border-bottom:solid #003366 1.5pt; padding:.75pt .75pt .75pt .75pt'> <p class=MsoNormal><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; mso-fareast-font-family:"Times New Roman";color:#003366'><a href="members.htm"><b><span style='color:#003366;letter-spacing:1.2pt; text-decoration:none;text-underline:none'>Members </span></b></a><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:6'> <td width=145 style='width:108.75pt;border:none;border-bottom:solid #003366 1.5pt; padding:.75pt .75pt .75pt .75pt'> <p class=MsoNormal><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; mso-fareast-font-family:"Times New Roman";color:#003366'><a href="publi.htm"><b><span style='color:#003366;letter-spacing:1.2pt;text-decoration:none;text-underline: none'>Publications</span></b></a><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:7'> <td width=145 style='width:108.75pt;border:none;border-bottom:solid #003366 1.5pt; padding:.75pt .75pt .75pt .75pt'> <p class=MsoNormal><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; mso-fareast-font-family:"Times New Roman";color:#003366'><a href="link.htm"><b><span style='color:#003366;letter-spacing:1.2pt;text-decoration:none;text-underline: none'>Links</span></b></a><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:8'> <td width=145 style='width:108.75pt;border:none;border-bottom:solid #003366 1.5pt; padding:.75pt .75pt .75pt .75pt'> <p class=MsoNormal><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; mso-fareast-font-family:"Times New Roman";color:#003366'><a href="innews.htm"><b><span style='color:#003366;letter-spacing:1.2pt; text-decoration:none;text-underline:none'>In the News</span></b></a><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:9'> <td width=145 style='width:108.75pt;border:none;border-bottom:solid #003366 1.5pt; padding:.75pt .75pt .75pt .75pt'> <p class=MsoNormal><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; mso-fareast-font-family:"Times New Roman";color:#003366'><a href="photo.htm"><b><span style='color:#003366;letter-spacing:1.2pt;text-decoration:none;text-underline: none'>Photo Gallery</span></b></a><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:10;mso-yfti-lastrow:yes'> <td width=145 style='width:108.75pt;border:none;border-bottom:solid #003366 1.5pt; padding:.75pt .75pt .75pt .75pt'> <p class=MsoNormal><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; mso-fareast-font-family:"Times New Roman";color:#003366'><a href="contact.htm"><b><span style='color:#003366;letter-spacing:1.2pt; text-decoration:none;text-underline:none'>Contact Us</span></b></a><o:p></o:p></span></p> </td> </tr> </table> </td> <td width="3%" style='width:3.0%;padding:0in 0in 0in 0in'> <p class=MsoNormal><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; mso-fareast-font-family:"Times New Roman";color:#003366'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p></span></p> </td> <td valign=top style='padding:0in 0in 0in 0in'> <h1><span style='font-family:"Verdana","sans-serif";mso-fareast-font-family: "Times New Roman";color:#003366'>Publications:<o:p></o:p></span></h1> <h1><span style='font-family:"Verdana","sans-serif";mso-fareast-font-family: "Times New Roman";color:#003366'>2012<o:p></o:p></span></h1> <p class=MsoBodyText style='margin-top:12.0pt;margin-right:-1.8pt;margin-bottom: 6.0pt;margin-left:0in;mso-line-height-alt:5.0pt;page-break-after:avoid; mso-outline-level:1;mso-hyphenate:none;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Zhang J*, <span class=SpellE>Sarkar</span> S*, <span class=SpellE>Cua</span> R, Zhou Y, <span class=SpellE>Hader</span> W, <b style='mso-bidi-font-weight: normal'>Yong VW</b>, A dialog between <span class=SpellE>glioma</span> and microglia that promotes tumor invasiveness through the CCL2/CCR2/interleukin-6 axis, Carcinogenesis 33:312-319, 2012 (*co-first authors)</span><span style='Sans";mso-font-kerning:.5pt;mso-fareast-language: HI'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-bidi-language: HI;mso-bidi-font-weight:bold'><o:p></o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE></span><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Casha</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> S, <span class=SpellE>Zygun</span> D, McGowan D, Baines I, <b style='mso-bidi-font-weight: normal'>Yong VW</b>, <span class=SpellE>Hurlbert</span> RJ, Results of a Phase II Placebo-Controlled Randomized Trial of <span class=SpellE>Minocycline</span> in Acute Spinal Cord Injury, Brain, in press<o:p></o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Sloka</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> S, <span class=SpellE>Mowbray</span> H, Wang J, <span class=SpellE>Verhaeghe</span> B, Fan Y, <span class=SpellE>Hader</span> W, <b>Yong VW</b>, <span style='mso-spacerun:yes'> </span>Normalization of microglia activity in a model of multiple sclerosis by <span class=SpellE>dipyridamole</span>, revised at GLIA<o:p></o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Lau L, <span class=SpellE>Keough</span> MB*, <span class=SpellE>Haylock</span>-Jacobs S*, <span class=SpellE>Cua</span> R, <span class=SpellE>Doring</span> A, <span class=SpellE>Sloka</span> S, <span class=SpellE>Stirling</span> DP, <span class=SpellE>Rivest</span> S, <b>Yong VW</b>, <span class=SpellE>Chondroitin</span> sulfate <span class=SpellE>proteoglycans</span> in <span class=SpellE>demyelinated</span> lesions impair <span class=SpellE>remyelination</span>, revised at Annals <span class=SpellE>Neurol</span> (*co-second authors)<o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:0in;margin-right:-1.8pt;margin-bottom: 0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-22.5pt;tab-stops: list 22.5pt left .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Sloka</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> JS, <b>Yong VW</b>, Benefit of vitamin D in a model of multiple sclerosis: Role of M2 macrophages and microglia, revised at J <span class=SpellE>Neuroimmunol</span><o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:12.0pt;margin-right:-1.8pt;margin-bottom: 6.0pt;margin-left:0in;mso-line-height-alt:5.0pt;page-break-after:avoid; mso-outline-level:1;mso-hyphenate:none;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif";mso-bidi-font-weight:bold'>Agrawal</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-bidi-font-weight: bold'> SM, Silva C, Wang J, Tong J, <b>Yong VW</b>, </span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>A novel anti-EMMPRIN function blocking antibody reduces T cell proliferation and neurotoxicity: Relevance to multiple sclerosis, revised at J <span class=SpellE>Neuroinflammation</span><o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:12.0pt;margin-right:-1.8pt;margin-bottom: 6.0pt;margin-left:0in;mso-line-height-alt:5.0pt;page-break-after:avoid; mso-outline-level:1;mso-hyphenate:none;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><a name="_GoBack"></a><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Lau L*, <span class=SpellE>Cua</span> R*, <span class=SpellE>Doring</span> A, <b>Yong VW</b>, Environmental cues in <span class=SpellE>remyelination</span>: Focus on the extracellular matrix and proteases, revised at Nature Rev Neuroscience </span><span style='EN-CA'><span lang=EN-CA style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-CA'>(*co-first authors)</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Casha</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> S*, Rice T*, <span class=SpellE>Stirling</span> DP*, McGowan D, Silva C, <span class=SpellE>Smekal</span> M, <span class=SpellE>Gnanapavan</span> S, <span class=SpellE>Zygun</span> D, <span class=SpellE>Giovannoni</span> G, <span class=SpellE>Hurlbert</span> J , <b style='mso-bidi-font-weight:normal'>Yong VW</b> , <span style='mso-spacerun:yes'> </span></span><span lang=EN-CA style='font-size: 10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language:EN-CA'>Human structural and inflammatory cerebrospinal fluid biomarkers after spinal cord injury, submitted (*co-first authors; co-senior authors)<o:p></o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Sarkar</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> S, <span class=SpellE>Doring</span> A, <span class=SpellE>Lun</span> X, Kelly J, <span class=SpellE>Hader</span> W, Dunn J, <span class=SpellE>Kinniburgh</span> D, Forsyth P, <span class=SpellE>Cairncross</span> G, Weiss S, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, Activation of <span class=SpellE>monocytoid</span> cells by <span class=SpellE><span style='bold'>amphotericin</span> B curbs the <span class=SpellE>tumorigenicity</span> of brain tumor-initiating cells, submitted</span><o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Lu JQ, Wilson BA, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, Pugh J, Mehta V, Potential autoimmune process in atypical <span class=SpellE>teratoid</span>/<span class=SpellE>rhabdoid</span> tumors, submitted<o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:12.0pt;margin-right:-1.8pt;margin-bottom: 6.0pt;margin-left:0in;mso-line-height-alt:5.0pt;page-break-after:avoid; mso-outline-level:1;mso-hyphenate:none;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Koch MW, Metz L, <span class=SpellE>Agrawal</span> S, <b style='mso-bidi-font-weight: normal'>Yong VW</b>, </span><span style='Sans";mso-font-kerning:.5pt;mso-fareast-language: HI'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-bidi-language: HI;mso-bidi-font-weight:bold'>Environmental factors and immunity in multiple sclerosis, submitted</span></span><span style='font-size:10.0pt;font-family: "Verdana","sans-serif"'><o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:12.0pt;margin-right:-1.8pt;margin-bottom: 6.0pt;margin-left:0in;mso-line-height-alt:5.0pt;page-break-after:avoid; mso-outline-level:1;mso-hyphenate:none;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Chang A, <span class=SpellE>Staugaitis</span> SM, <span class=SpellE>Dutta</span> R, <span class=SpellE>Batt</span> CE, Easley KE, <span class=SpellE>Chomyk</span> AM, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, Fox RJ, Kidd GJ, Trapp BD, Cortical <span class=SpellE>remyelination</span>: A new target for repair therapies in multiple sclerosis, submitted<o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:12.0pt;margin-right:-1.8pt;margin-bottom: 6.0pt;margin-left:0in;mso-line-height-alt:5.0pt;page-break-after:avoid; mso-outline-level:1;mso-hyphenate:none;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Mishra</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> M, Wang J, Silva C, Mack M, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, <span style='mso-bidi-font-weight:bold'>Relationship between circulating pro-inflammatory <span class=SpellE>monocytes</span> with disease severity in a model of multiple sclerosis: perturbation by <span class=SpellE>laquinimod</span>, submitted</span><o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:12.0pt;margin-right:-1.8pt;margin-bottom: 6.0pt;margin-left:0in;mso-line-height-alt:5.0pt;page-break-after:avoid; mso-outline-level:1;mso-hyphenate:none;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Doring</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> A, <span class=SpellE>Sloka</span> S, <span class=SpellE>Agrawal</span> S, Lau L, <span class=SpellE>Mishra</span> M, van <span class=SpellE>Minnen</span> J, Zhang Z, <span class=SpellE>Kinniburgh</span> D, van <span class=SpellE>Rooijen</span> N, <span class=SpellE>Rivest</span> S, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, Therapeutic Stimulation of <span class=SpellE>Monocytoid</span> Cells Promotes <span class=SpellE>Remyelination</span>, submitted <o:p></o:p></span></p> <h1><span style='font-family:"Verdana","sans-serif";mso-fareast-font-family: "Times New Roman";color:#003366'><o:p>&nbsp;</o:p></span></h1> <h1><span style='font-family:"Verdana","sans-serif";mso-fareast-font-family: "Times New Roman";color:#003366'>2011<o:p></o:p></span></h1> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Agrawal</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> S, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, <span style='mso-spacerun:yes'> </span><span class=ti2><span style='mso-ansi-font-size: 10.0pt;mso-bidi-font-size:10.0pt;font-family:"Verdana","sans-serif"'>The many faces of EMMPRIN - roles in <span class=SpellE>neuroinflammation</span>, <span class=SpellE>Biochem</span> <span class=SpellE>Biophys</span> <span class=SpellE>Acta</span>, in </span></span>Molecular Basis of Disease Special Issue: Multiple Sclerosis, 1812:213-219, 2011</span><span style='EN-CA'><span lang=EN-CA style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-CA'><o:p></o:p></span></p> <p class=MsoListParagraph><span lang=EN-CA style='font-family:"Verdana","sans-serif"; mso-ansi-language:EN-CA'></span><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span style='EN-CA'><span class=SpellE><span lang=EN-CA style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-CA'>Sloka</span></span><span lang=EN-CA style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-CA'> S, Silva C, <span class=SpellE>Pryse</span>-Phillips W, Patten S, Metz L, <b>Yong VW</b>, A </span>quantitative analysis of suspected environmental causes of MS, Can J <span class=SpellE>Neurol</span> <span class=SpellE>Sci</span> </span><span style='font-size:10.0pt;font-family: "Verdana","sans-serif"'>38:98-105, 2011<span style='color:black'><o:p></o:p></span></span></p> <p class=MsoListParagraph><span style='font-family:"Verdana","sans-serif"; color:black'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Agrawal</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> SM, Silva C, <span class=SpellE>Tourtellotte</span> WW, <b>Yong VW</b>, EMMPRIN: A novel regulator of <span class=SpellE>neuroinflammation</span> in multiple sclerosis and experimental autoimmune encephalomyelitis, J <span class=SpellE>Neurosci</span> <span class=src1><span style='font-family:"Verdana","sans-serif"'>31:669-677, 2011<o:p></o:p></span></span></span></p> <p class=MsoBodyText style='margin-right:-1.8pt'><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Kwon B, <span class=SpellE>Casha</span> S, <span class=SpellE>Hurlbert</span> RJ, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, <span style='mso-spacerun:yes'> </span>Inflammatory and Structural Biomarkers in Acute Traumatic Spinal Cord Injury, Clinical Chemistry and Laboratory Medicine 49:425-33,2011<o:p></o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt'><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Broadwater L, <span class=SpellE>Pandit</span> A, <span class=SpellE>Azzam</span> S<sub>, </sub>Clements R, <span class=SpellE>Vadnal</span> J, <b style='mso-bidi-font-weight: normal'>Yong VW</b>, Freeman EJ, Gregory RB, McDonough J, Analysis of the Mitochondrial Proteome in Multiple Sclerosis Cortex, </span><span class=SpellE><span lang=EN-CA style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-CA'>Biochimica</span></span><span lang=EN-CA style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-CA'> et <span class=SpellE>Biophysica</span> <span class=SpellE>Acta</span> - Molecular Basis of Disease </span><span style='font-size:10.0pt;font-family: "Verdana","sans-serif"'>1812:630-41</span><span style='EN-CA'><span lang=EN-CA style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-CA;mso-fareast-language:EN-CA'>,2011</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p></o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt'><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Doring</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> A, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, The good, the bad and the ugly of macrophages/microglia with a focus on myelin repair, Frontiers in Bioscience, 3:846-856 2011.<o:p></o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Sloka</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> S, Silva C, Wang J, Metz L, <b>Yong VW</b>, Predominance of Th2 polarization by Vitamin D through a Stat6-dependent mechanism, J <span class=SpellE>Neuroinflammation</span> 8:56, 2011<o:p></o:p></span></p> <p class=MsoListParagraph><span style='font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bar-Or A, <span class=SpellE>Reickmann</span> P, <span class=SpellE>Traboulsee</span> A, <b>Yong VW</b>, Targeting Progressive <span class=SpellE>Neuroaxonal</span> Injury: Lessons From Multiple Sclerosis, CNS Drugs<span style='color:black'> </span>25:783-799, 2011<span style='color:black'><o:p></o:p></span></span></p> <p class=MsoListParagraph><span style='font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Haylock</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>-Jacobs S, <span class=SpellE>Keough</span> MB, Lau L, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, <span class=SpellE>Chondroitin</span> sulfate <span class=SpellE>proteoglycans</span>: Extracellular matrix proteins that regulate immunity of the central nervous system, Autoimmunity Reviews 10:766-772, 2011<o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:12.0pt;margin-right:-1.8pt;margin-bottom: 6.0pt;margin-left:0in;mso-line-height-alt:5.0pt;page-break-after:avoid; mso-outline-level:1;mso-hyphenate:none;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Kucharova</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> K, Chang Y, Boor A, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, <span class=SpellE>Stallcup</span> W, Reduction of both myelin damage and myelin repair in the NG2 null mouse after <span class=SpellE>demyelination</span>, J <span class=SpellE>Neuroinflammation</span> 8:158, 2011</span><span style='.5pt'><span style='font-size:10.0pt; font-family:"Verdana","sans-serif";mso-fareast-language:HI;mso-bidi-language: HI;mso-bidi-font-weight:bold'><o:p></o:p></span></p> <h1><span style='font-family:"Verdana","sans-serif";mso-fareast-font-family: "Times New Roman";color:#003366'></span><o:p>&nbsp;</o:p></span></h1> <h1><span style='font-family:"Verdana","sans-serif";mso-fareast-font-family: "Times New Roman";color:#003366'>2010<o:p></o:p></span></h1> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><b><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Yong VW</span></b><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>, Marks S, The interplay between the immune and central nervous systems in neuronal injury, <span class=SpellE>Neurol</span> <span style='mso-spacerun:yes'> </span><span class=src1><span style='font-family: "Verdana","sans-serif"'>74 <span class=SpellE>Suppl</span> 1:S9-S16, 2010<span style='color:black'><o:p></o:p></span></span></span></span></p> <p class=MsoBodyText style='margin-top:0in;margin-right:-1.8pt;margin-bottom: 0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-22.5pt;tab-stops: list 22.5pt left .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span class=src1><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"; color:black'><o:p>&nbsp;</o:p></span></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span lang=EN-CA style='font-size: 10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language:EN-CA'>Sarkar</span></span><span lang=EN-CA style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-CA'> S, <b>Yong VW</b>, Reduction of protein <span class=SpellE>kinase</span> C delta attenuates <span class=SpellE>tenascin</span>-C stimulated <span class=SpellE>glioma</span> invasion in three-dimensional matrix, Carcinogenesis </span><span class=src1><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>31:311-317, 2010</span></span><span class=src1><span lang=EN-CA style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-CA'><o:p></o:p></span></span></p> <p class=MsoBodyText style='margin-top:0in;margin-right:-1.8pt;margin-bottom: 0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-22.5pt;tab-stops: list 22.5pt left .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='black'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> </span> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span lang=EN-CA style='font-size: 10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language:EN-CA'>Xue</span></span><span lang=EN-CA style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-CA'> M, <span class=SpellE>Mikliaeva</span> E, <span class=SpellE>Casha</span> S, <span class=SpellE>Zygun</span> D, <span class=SpellE>Demchuk</span> A, <b>Yong VW</b>, Improving outcomes of <span class=SpellE>neuroprotection</span> by <span class=SpellE>minocycline</span>: Guides from cell culture and <span class=SpellE>intracerebral</span> <span class=SpellE>hemorrhage</span> in mice, American J <span class=SpellE>Pathol</span> </span><span class=src1><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>176:1193-2202, 2010</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:0in;margin-right:-1.8pt;margin-bottom: 0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-22.5pt;tab-stops: list 22.5pt left .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Rodrigues</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> JC, Gonzalez GC, Zhang L, Ibrahim G, Kelly JJP, Forsyth PA, <b style='mso-bidi-font-weight: normal'>Yong VW</b>, <span class=SpellE>Parney</span> IF, Normal human <span class=SpellE>monocytes</span> exposed to <span class=SpellE>glioma</span> cells acquire myeloid-derived suppressor cell-like properties, <span class=SpellE>NeuroOncology</span> 12:351-365, 2010<o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:0in;margin-right:-1.8pt;margin-bottom: 0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-22.5pt;tab-stops: list 22.5pt left .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><span style='mso-spacerun:yes'> </span><span style='mso-spacerun:yes'> </span>Lu JQ, Joseph JT, Nash RA, <span class=SpellE>Storek</span> J, Stevens AM, Metz L, Clark AW, Johnson ES, <b>Yong VW</b>, Inflammation and <span class=SpellE>demyelination</span> in multiple sclerosis after <span class=SpellE>allogeneic</span> hematopoietic stem cell Transplantation, Arch <span class=SpellE>Neurol</span> 67:716-722, 2010<o:p></o:p></span></p> <p class=MsoListParagraph><span style='font-family:"Verdana","sans-serif"; color:black'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Yong VW,<span style='mso-spacerun:yes'>  </span>Inflammation in neurological disorders: A help or a hindrance, The Neuroscientist 16:408-420, 2010<span style='color:black'><o:p></o:p></span></span></p> <p class=MsoListParagraph><span style='font-family:"Verdana","sans-serif"; color:black'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span lang=EN-CA style='font-size: 10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language:EN-CA'>Goncalves</span></span><span lang=EN-CA style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-CA'> <span class=SpellE>DaSilva</span> A, <span class=SpellE>Liaw</span> L, <b style='mso-bidi-font-weight:normal'>Yong VW,</b><span style='mso-spacerun:yes'>  </span></span><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Cleavage of <span class=SpellE>osteopontin</span> by matrix metalloproteinase-12 (MMP-12) modulates severity of experimental autoimmune encephalomyelitis,<span style='EN-CA'> </span><span lang=EN-CA style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-CA'>American J <span class=SpellE>Pathol</span> 177:1448-1458, 2010</span><o:p></o:p></span></p> <p class=MsoListParagraph><span lang=EN-CA style='font-family:"Verdana","sans-serif"; mso-ansi-language:EN-CA'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Zhang Y, Metz LM, <b>Yong VW</b>, Mitchell RJ, Baseline deep gray matter  black T2 predicts third-year disability in multiple sclerosis, J <span class=SpellE>Neurol</span> <span class=SpellE>Sci</span> <span class=src1><span style='font-family:"Verdana","sans-serif"'>297:76-81, 2010<span style='color:black'><o:p></o:p></span></span></span></span></p> <p class=MsoListParagraph><span style='font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Carnini</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> A, <span class=SpellE>Hurlbert</span> RJ, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, <span class=SpellE>Casha</span> S, Braun JEA, Reduction of <span class=SpellE>PrP<sup>C</sup></span> in Human Cerebrospinal Fluid after Spinal Cord Injury, <span class=SpellE>Prion</span> <span class=src1><span style='font-family:"Verdana","sans-serif"'>4:80-86, 2010<span style='color:black'><o:p></o:p></span></span></span></span></p> <p class=MsoListParagraph><span style='mso-bidi-font-size:12.0pt;font-family: "Verdana","sans-serif";color:black'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-top:0in;margin-right:-1.8pt;margin-bottom: 0in;margin-left:22.5pt;margin-bottom:.0001pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span style='mso-bidi-font-size:12.0pt;font-family: "Verdana","sans-serif";color:black'><o:p>&nbsp;</o:p></span></p> <h1><span style='font-family:"Verdana","sans-serif";mso-fareast-font-family: "Times New Roman";color:#003366'>2009<o:p></o:p></span></h1> <p class=MsoBodyText style='margin-top:12.0pt;margin-right:-1.8pt;margin-bottom: 6.0pt;margin-left:0in;mso-line-height-alt:5.0pt;page-break-after:avoid; mso-outline-level:1;mso-hyphenate:none;layout-grid-mode:both'><u1:p><span style='mso-bidi-font-size:12.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Sarkar</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> S, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, Inflammatory cytokine modulation of matrix metalloproteinase expression and invasiveness of <span class=SpellE>glioma</span> cells in a 3<b style='mso-bidi-font-weight:normal'>-</b>dimensional collagen matrix, J <span class=SpellE>Neurooncology</span> 91:157-164, 2009<o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:0in;margin-right:-1.8pt;margin-bottom: 0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-22.5pt;tab-stops: list 22.5pt left .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Xue</span></span><span style='font-size: 10.0pt;font-family:"Verdana","sans-serif"'> M, Fan Y, Liu S, <span class=SpellE>Zygun</span> D, <span class=SpellE>Demchuk</span> A, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, Contributions of multiple proteases to neurotoxicity in a mouse model of <span class=SpellE>intracerebral</span> hemorrhage, Brain 132:26-36, 2009<o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:0in;margin-right:-1.8pt;margin-bottom: 0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-22.5pt;tab-stops: list 22.5pt left .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Lu JQ, Metz L, <span class=SpellE>Storek</span> J, <b style='mso-bidi-font-weight: normal'>Yong VW</b>, Nash RA, Joseph JT, Continued disease activity of multiple sclerosis after <span class=SpellE>allogeneic</span> hematopoietic cell transplantation in a complete chimera: case report with <span class=SpellE>histopathological</span> findings, Arch <span class=SpellE>Neurol</span> 66:116-120, 2009<o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:0in;margin-right:-1.8pt;margin-bottom: 0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-22.5pt;tab-stops: list 22.5pt left .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Stirling</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> DP, Liu S, <span class=SpellE>Kubes</span> P, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, Depletion of Ly6G/Gr-1 leukocytes after spinal cord injury in mice alters <span style='black'>wound healing events and worsens neurological outcome, J <span class=SpellE>Neurosci</span> </span>29 753-764, 2009<o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:0in;margin-right:-1.8pt;margin-bottom: 0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-22.5pt;tab-stops: list 22.5pt left .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Lu JQ, Fan Y, <span class=SpellE>Mitha</span> AP, Bell R, Metz L, Moore W, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, Association of ±-<span class=SpellE>synuclein</span> <span class=SpellE>immunoreactivity</span> with inflammatory activity in multiple sclerosis lesions, J Neuropath Exp <span class=SpellE>Neurol</span> 68:179-189, 2009<o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:0in;margin-right:-1.8pt;margin-bottom: 0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-22.5pt;tab-stops: list 22.5pt left .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Yong VW</span></b><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>, Prospects of repair in multiple sclerosis, J <span class=SpellE>Neurol</span> <span class=SpellE>Sci</span> 277S1:S16-S18, 2009<o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:0in;margin-right:-1.8pt;margin-bottom: 0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-22.5pt;tab-stops: list 22.5pt left .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Goncalves</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> <span class=SpellE>DaSilva</span> A, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, Matrix metalloproteinase-12 deficiency worsens relapsing-remitting experimental autoimmune encephalomyelitis through cytokine and <span class=SpellE>chemokine</span> <span class=SpellE>dysregulation</span>, American J <span class=SpellE>Pathol</span> 174:898-909, 2009<o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:0in;margin-right:-1.8pt;margin-bottom: 0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-22.5pt;tab-stops: list 22.5pt left .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Xue</span></span><span style='font-size: 10.0pt;font-family:"Verdana","sans-serif"'> M, <span class=SpellE>Hollenberg</span> MD, <span class=SpellE>Demchuk</span> A, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, Relative importance of <span class=SpellE>proteinase</span>-activated receptor<span style='ZH-CN'>-1</span> versus <span style='bold'>matrix <span class=SpellE>metalloproteinases</span> in <span class=SpellE>intracerebral</span> hemorrhage-mediated neurotoxicity in mice, Stroke 40:2199-2204, 2009</span><o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:0in;margin-right:-1.8pt;margin-bottom: 0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-22.5pt;tab-stops: list 22.5pt left .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span lang=EN-CA style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-CA'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span lang=EN-CA style='font-size:10.0pt;font-family: "Verdana","sans-serif";mso-ansi-language:EN-CA'>McCreary CR, <span class=SpellE>Bjarnason</span> TA, <span class=SpellE>Skihar</span> V, Mitchell JR, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, Dunn JF, </span><span class=SpellE><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Multiexponential</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> T<sub>2</sub> and Magnetization Transfer MRI of <span class=SpellE>Demyelination</span> and <span class=SpellE>Remyelination</span> in <span class=SpellE>Murine</span> Spinal Cord, <span class=SpellE>Neuroimage</span> 45:1173-1182, 2009<o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:0in;margin-right:-1.8pt;margin-bottom: 0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-22.5pt;tab-stops: list 22.5pt left .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span lang=EN-CA style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-CA'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span lang=EN-CA style='font-size: 10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language:EN-CA'>Kalyvas</span></span><sup><span lang=EN-CA style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-CA'> </span></sup><span lang=EN-CA style='font-size: 10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language:EN-CA'>A, </span><span class=SpellE><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Baskakis</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> C, <span class=SpellE><span style='color:black'>Magrioti</span></span><span style='color:black'> V</span>, <span class=SpellE><span style='color:black'>Constantinou-Kokotou</span></span><span style='color:black'> V</span>, Stephens D, <span class=SpellE>López</span>-Vales R, <span style='color:black'>Lu JQ, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, </span>Dennis EA, <span class=SpellE>Kokotos</span> G, David S, Differing roles for members of the <span class=SpellE>Phospholipase</span> A2 <span class=SpellE>superfamily</span> in experimental autoimmune encephalomyelitis, Brain 132:1221-1235, 2009<o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:0in;margin-right:-1.8pt;margin-bottom: 0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-22.5pt;tab-stops: list 22.5pt left .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Ellestad</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> K, <span class=SpellE>Tsutsui</span> S, <span class=SpellE>Noorbakhsh</span> F, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, Pittman QJ, Power C, Early <span style='color:black'>life exposure to <span class=SpellE>lipopolysaccaride</span> suppresses experimental autoimmune encephalomyelitis by promoting <span class=SpellE>tolerogenic</span> <span class=SpellE>dendritic</span> cells and regulatory T cells, J <span class=SpellE>Immunol</span> </span>183:298-309, 2009</span><span style='EN-CA'><span lang=EN-CA style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-CA'><o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:0in;margin-right:-1.8pt;margin-bottom: 0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-22.5pt;tab-stops: list 22.5pt left .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span lang=EN-CA style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-CA'><o:p>&nbsp;</o:p></span></p> </span> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><b><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Yong VW</span></b><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>, <span class=SpellE>Rivest</span> S, Taking advantage of the systemic immune system to cure brain diseases, Neuron 64:55-60, 2009<o:p></o:p></span><span style='black'></p> <p class=MsoBodyText style='margin-top:0in;margin-right:-1.8pt;margin-bottom: 0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-22.5pt;tab-stops: list 22.5pt left .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> </span> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>`iaková</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> Z, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, Hoekstra D, Baron W, <span class=SpellE>Fibronectin</span> perturbs process outgrowth in <span class=SpellE>oligodendrocytes</span> by <span class=SpellE>misregulating</span> MMP-9 activity, Molecular and Cellular Neuroscience 42:234-242, 2009</span><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'><o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:0in;margin-right:-1.8pt;margin-bottom: 0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-22.5pt;tab-stops: list 22.5pt left .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoBodyText style='margin-right:-1.8pt;tab-stops:.3in .8in 1.3in list 117.25pt left 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in; layout-grid-mode:both'><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Skihar</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> V, Silva C, <span class=SpellE>Chojnacki</span> A, <span class=SpellE>Doering</span> A, <span class=SpellE>Stallcup</span> WB, Weiss S, <b>Yong VW</b>, Promoting <span class=SpellE>oligodendrogenesis</span> and myelin repair using the multiple sclerosis medication <span class=SpellE>glatiramer</span> acetate, Proc <span class=SpellE>Natl</span> <span class=SpellE>Acad</span> <span class=SpellE>Sci</span> USA 106:17992-17997, 2009</span><span style='EN-GB'><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'><o:p></o:p></span></p> <p class=MsoBodyText style='margin-top:0in;margin-right:-1.8pt;margin-bottom: 0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-22.5pt;tab-stops: list 22.5pt left .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span lang=EN-CA style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-CA'><o:p>&nbsp;</o:p></span></p> </span> <p class=MsoBodyText style='margin-left:22.5pt;text-indent:-22.5pt; tab-stops:list .25in left .3in .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Metz LM, Li D, <span class=SpellE>Traboulsee</span> A, Myles ML, <span class=SpellE>Duquette</span> P, <span class=SpellE>Godin</span> J, <span class=SpellE>Constantin</span> M, <b style='mso-bidi-font-weight:normal'>Yong VW</b> for the GA/<span class=SpellE>minocycline</span> study investigators, <span class=SpellE>Glatiramer</span> Acetate in Combination with <span class=SpellE>Minocycline</span> in Patients with Relapsing-Remitting Multiple Sclerosis: Results of a Canadian, Multicenter, Double-Blind, Placebo-Controlled Trial, Multiple Sclerosis, <span class=src1><span style='font-family:"Verdana","sans-serif"'>15:1183-1194, 2009<o:p></o:p></span></span></span></p> <p class=MsoBodyText style='margin-left:22.5pt;text-indent:-22.5pt; tab-stops:list .25in left .3in .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <h1><span style='font-family:"Verdana","sans-serif";mso-fareast-font-family: "Times New Roman";color:#003366'>2008<o:p></o:p></span></h1> <p class=MsoBodyText2 style='margin-left:22.5pt;text-indent:-22.5pt; tab-stops:list .25in left .3in .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span lang=EN-GB style='mso-bidi-font-size:12.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'><u1:p>&nbsp;</u1:p> <u1:p>&nbsp;</u1:p> </span><span style='font-family:"Verdana","sans-serif"'><o:p></o:p></span></p> <p class=MsoBodyText2 style='margin-left:22.5pt;text-indent:-22.5pt; tab-stops:list .25in left .3in .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span class=SpellE><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Agrawal</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> SM, Lau L, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, MMPs in the Central Nervous System: Where the Good Guys Go Bad, Seminars Cell and Dev <span class=SpellE>Biol</span> <br> 19:42-51, 2008</span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'> </span><span style='font-size:10.0pt;font-family: "Verdana","sans-serif"'><u1:p></u1:p><o:p></o:p></span></p> <p class=MsoBodyText2 style='margin-left:22.5pt;text-indent:-22.5pt; tab-stops:list .25in left .3in .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><u1:p><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>&nbsp;</u1:p> <o:p></o:p></span></p> <p class=MsoBodyText2 style='margin-left:22.5pt;text-indent:-22.5pt; tab-stops:list .25in left .3in .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'>Zhang Y, Metz LM, <b style='mso-bidi-font-weight: normal'>Yong VW,</b> Bell RB, <span class=SpellE>Yeung</span> M, <span class=SpellE>Patry</span> DG, Mitchell RJ, </span><span style='font-size: 10.0pt;font-family:"Verdana","sans-serif"'>Pilot Trial of <span class=SpellE>Minocycline</span> in Relapsing <br> Remitting Multiple Sclerosis, Can J <span class=SpellE>Neurol</span> <span class=SpellE>Sci</span> 35:185-191, 2008<a name="OLE_LINK1"> <o:p></o:p></a></span></p> <u1:p></u1:p> <p class=MsoBodyText2 style='margin-left:22.5pt;text-indent:-22.5pt; tab-stops:list .25in left .3in .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><u1:p>&nbsp;</u1:p> <o:p></o:p></span></p> <p class=MsoBodyText2 style='margin-left:22.5pt;text-indent:-22.5pt; tab-stops:list .25in left .3in .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span class=SpellE><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Stirling</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> DP, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, Dynamics of the inflammatory response after <span class=SpellE>murine</span> spinal cord injury revealed by flow <span class=SpellE>cytometry</span>, <br> J <span class=SpellE>Neurosci</span> Res 86:1944-1958, 2008<o:p></o:p></span></p> <p class=MsoBodyText2 style='margin-left:22.5pt;text-indent:-22.5pt; tab-stops:list .25in left .3in .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><u1:p>&nbsp;</u1:p> <o:p></o:p></span></p> <p class=MsoBodyText2 style='margin-left:22.5pt;text-indent:-22.5pt; tab-stops:list .25in left .3in .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span class=SpellE><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Goncalves</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> <span class=SpellE>DaSilva</span> A, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, Expression and regulation of matrix metalloproteinase-12 in experimental autoimmune encephalomyelitis<br> and in culture, J <span class=SpellE>Neuroimmunol</span> 199:24-24, 2008 <u1:p></u1:p><o:p></o:p></span></p> <p class=MsoBodyText2 style='margin-left:22.5pt;text-indent:-22.5pt; tab-stops:list .25in left .3in .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><u1:p>&nbsp;</u1:p> <o:p></o:p></span></p> <p class=MsoBodyText2 style='margin-left:22.5pt;text-indent:-22.5pt; tab-stops:list .25in left .3in .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span class=SpellE><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Casha</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> S, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, <span class=SpellE>Midha</span> R, <span class=SpellE>Minocycline</span> for Axonal Regeneration After Nerve Injury: A Double-Edged Sword, <br> editorial for Exp <span class=SpellE>Neurol</span> <span class=volume>213</span>:<span class=pages>245-248, 2008 </span><o:p></o:p></span></p> <u1:p></u1:p> <p class=MsoBodyText2 style='margin-left:22.5pt;text-indent:-22.5pt; tab-stops:list .25in left .3in .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><u1:p>&nbsp;</u1:p> <o:p></o:p></span></p> <p class=MsoBodyText2 style='margin-left:22.5pt;text-indent:-22.5pt; tab-stops:list .25in left .3in .8in 1.3in 1.8in 2.3in 2.8in 3.3in 3.8in 4.3in 4.8in 5.3in 5.8in 6.3in 6.8in'><span class=SpellE><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Xue</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> M, <b style='mso-bidi-font-weight:normal'>Yong VW</b>, </span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-fareast-language: ZH-CN'>Matrix <span class=SpellE>metalloproteinases</span> </span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>in <span class=SpellE>intracerebral</span> hemorrhage, <span class=SpellE>Neurol</span> Res 30:775-782, 2008 <o:p></o:p></span></p> <u1:p></u1:p> <h1><span style='font-family:"Verdana","sans-serif";mso-fareast-font-family: "Times New Roman";color:#003366'>2007<o:p></o:p></span></h1> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/07/Nuttall%20et%20al.%20Glia%2055,%20516,%202007.pdf"><span class=SpellE><b>Nuttall</b></span><b> RK, Silva C, Bar-Or A, Patel K, Edwards DR, Yong VW, <span class=SpellE>Metalloproteinases</span> (MMPs and ADAMs) are enriched in microglia compared to leukocytes and they link microglia activation with cytokine levels, GLIA 55:516-526, 2007</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/07/Gregg%20et%20al.,%20J%20Neurosci.%2027,%201812,%20%202007.pdf"><b>Gregg C, <span class=SpellE>Shikar</span> V, Larsen P, <span class=SpellE>Mak</span> G, <span class=SpellE>Chojnacki</span> A, Yong VW, Weiss S, White matter plasticity and enhanced <span class=SpellE>remyelination</span> in the maternal CNS, J <span class=SpellE>Neurosci</span> 27:1812-1823, 2007</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/07/Rice%20et%20al.,%20J%20Neuropathol%20Exp%20Neurol.66,%20184,%202007.pdf"><b>Rice T, Larsen J, <span class=SpellE>Rivest</span> S, Yong VW, Characterization of the early <span class=SpellE>neuroinflammation</span> after spinal cord injury in mice, J Neuropath Exp <span class=SpellE>Neurol</span> 66:184-195, 2007</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/07/Zabad%20et%20al.,%20Mult%20Scler.%2013,%20517,%202007.pdf"><span class=SpellE><b>Zabad</b></span><b> RK, Metz LM, <span class=SpellE>Todoruk</span> TR, Zhang Y, Mitchell JR, <span class=SpellE>Yeung</span> M, <span class=SpellE>Patry</span> DG, Bell, RM, Yong VW, The clinical response to <span class=SpellE>minocycline</span> in MS is accompanied by immune changes, Multiple Sclerosis Journal 13:517-526, 2007</b></a><o:p></o:p></span></p> <p><span class=SpellE><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'>Agrawal</span></span><span style='font-size:8.5pt;font-family: "Verdana","sans-serif";color:#003366'> SM, <b>Yong VW</b>, <span class=SpellE>Immunopathogenesis</span> of multiple sclerosis, in Neurobiology of Multiple Sclerosis, <span class=SpellE>Int</span> Rev <span class=SpellE>Neurobiol</span> 79C:99-126, 2007<o:p></o:p></span></p> <p><b><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'>Yong VW</span></b><span style='font-size:8.5pt;font-family: "Verdana","sans-serif";color:#003366'>, Giuliani F, <span class=SpellE>Xue</span> M, Bar-Or, Metz LM, Experimental models of <span class=SpellE>neuroprotection</span> relevant to multiple sclerosis, Neurology S32-S37, 2007<o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/07/Yong%20et%20al.,%20J%20Neurol%20Sci.%20Epub,%202007.pdf"><b>Yong VW, <span class=SpellE>Zabad</span> RK, <span class=SpellE>Agrawal</span> S, <span class=SpellE>Goncalves</span> <span class=SpellE>DaSilva</span> A, Metz LM, Elevation of Matrix <span class=SpellE>Metalloproteinases</span> (MMPs) in Multiple Sclerosis and Impact of <span class=SpellE>Immunomodulators</span>, J <span class=SpellE>Neurol</span> <span class=SpellE>Sci</span> 259:79-84, 2007</b></a><o:p></o:p></span></p> <p><span class=SpellE><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'>Schellenberg</span></span><span style='font-size:8.5pt; font-family:"Verdana","sans-serif";color:#003366'> AE, <span class=SpellE>Buist</span> R, <b>Yong VW</b>, Del <span class=SpellE>Bigio</span> MR, Peeling J, Magnetic resonance imaging of blood-spinal cord barrier disruption in mice with experimental autoimmune encephalomyelitis, <span class=SpellE>Mag</span> <span class=SpellE>Reson</span> Med 58:298-305, 2007<o:p></o:p></span></p> <p><b><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'>Yong VW</span></b><span style='font-size:8.5pt;font-family: "Verdana","sans-serif";color:#003366'>, <span class=SpellE>Agrawal</span> SM, <span class=SpellE>Stirling</span> DP, Targeting MMPs in acute and chronic neurological conditions, <span class=SpellE>NeuroRx</span>, special volume on <span class=SpellE>Neuroimmunology</span> in <span class=SpellE>Neurotherapeutics</span> 4:580-589, 2007<o:p></o:p></span></p> <h1><span style='font-family:"Verdana","sans-serif";mso-fareast-font-family: "Times New Roman";color:#003366'>2006<o:p></o:p></span></h1> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'>Larsen PH, <span class=SpellE>Goncalves</span> <span class=SpellE>DaSilva</span> A, Conant K, <b>Yong VW</b>, Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and -12 null mice, J <span class=SpellE>Neurosci</span> 26:2207-2214, 2006<o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/06/Song%20et%20al.,%20%20JNeurosci%20%2026,%203299,%202006.pdf"><b>Song JH, <span class=SpellE>Bellail</span> A, <span class=SpellE>Tse</span> MC, Yong VW, <span class=SpellE>Hao</span> C, Human <span class=SpellE>astrocytes</span> are resistant to <span class=SpellE>Fas</span> <span class=SpellE>ligand</span> and tumor necrosis factor-related apoptosis-inducing <span class=SpellE>ligand</span>-induced apoptosis, J <span class=SpellE>Neurosci</span> 26:3299-3308, 2006</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/06/janke%20and%20yong,%20neurol%20res%2028,%20270,%202006.pdf"><span class=SpellE><b>Janke</b></span><b> AD, Yong VW, Impact of <span class=SpellE>IVIg</span> on the interaction between activated T cells and microglia, <span class=SpellE>Neurol</span> Res 28:270-274, 2006</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/06/Wang%20CX.,%20et%20al,%20Cell%20Death%20Differ%2013,%201203,%202006.pdf"><b>Wang CX, Song JH, Song DK, Yong VW, <span class=SpellE>Shuaib</span> A, <span class=SpellE>Hao</span> C, <span class=SpellE>Cyclin</span>-dependent kinase-5 prevents neuronal apoptosis through ERK-mediated <span class=SpellE>upregulation</span> of Bcl-2, Cell, death and differentiation 13:1203-1212, 2006</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/06/Dhib-Jalbut%20S.%20et%20al.,%20JNI,%20176,%20198,%202006.pdf"><span class=SpellE><b>Dhib-Jalbut</b></span><b> S, Arnold DL, Cleveland DW, Fisher M, Friedlander RM, <span class=SpellE>Mouradian</span> MM, <span class=SpellE>Przedborski</span> S, Trapp BD, Wyss-<span class=SpellE>Coray</span> T, Yong VW, <span class=SpellE>Neurodegeneration</span> and <span class=SpellE>Neuroprotection</span> in Multiple Sclerosis and Other Neurodegenerative Diseases, J <span class=SpellE>Neuroimmunol</span> 176:198-215, 2006</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/06/Janke%20A.,%20et%20al.,%20JI%20177,%20181,%202006.pdf"><span class=SpellE><b>Janke</b></span><b> AD, Giuliani F, Yong VW, <span class=SpellE>IVIg</span> attenuates T cell-mediated killing of human neurons, J <span class=SpellE>Neuroimmunol</span> 177:181-188, 2006</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/06/zhang%20et%20al.,%20Lecture%20Notes%20in%20Computer%20Science%202006.pdf"><b>Zhang Y, Wells J, <span class=SpellE>Buist</span> R, Peeling J, Yong VW, Mitchell JR, A novel MRI texture analysis of <span class=SpellE>demyelination</span> and inflammation in relapsing-remitting experimental allergic encephalomyelitis, Med Image <span class=SpellE>Comput</span> 9:760-767, 2006</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/06/Xue%20M.,%20et%20al.,%20JNeurosci%2026,%2010281,%202006.pdf"><span class=SpellE><b>Xue</b></span><b> M, <span class=SpellE>Hollenberg</span> M, Yong VW, Combination of thrombin and matrix metalloproteinase-9 exacerbates neurotoxicity in cell culture and <span class=SpellE>intracerebral</span> hemorrhage in mice, J <span class=SpellE>Neurosci</span> 26:10281-10291, 2006</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/06/Sarkar%20et%20al.,%20Cancer%20Research%2066,%2011771,%20%202006.pdf"><span class=SpellE><b>Sarkar</b></span><b> S, <span class=SpellE>Nuttall</span> RK, Edwards DR, Yong VW, <span class=SpellE>Tenascin</span>-C stimulates <span class=SpellE>glioma</span> cell invasion through matrix metalloproteinase-12, Cancer Res 66:11771-11780, 2006</b></a><o:p></o:p></span></p> <h1><span style='font-family:"Verdana","sans-serif";mso-fareast-font-family: "Times New Roman";color:#003366'>2005<o:p></o:p></span></h1> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/05/Giuliani%20et%20al.,%20JNI%20158,%20213,%202005.pdf"><b>Giuliani F, Metz LM, Wilson T, Fan Y, Bar-Or A, Yong VW, Additive effect of the combination of <span class=SpellE>glatiramer</span> acetate and <span class=SpellE>minocycline</span> in a model of MS, J <span class=SpellE>Neuroimmunol</span> 158:213-221, 2005</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/05/Wells%20et%20al.,%20Eur%20J%20Neurosci%2021,%20187,%202005.pdf"><b>Wells JEA, <span class=SpellE>Biernaskie</span> J, <span class=SpellE>Szymanska</span> A, Corbett DR, Yong VW, Matrix metalloproteinase (MMP)-12 expression has a negative impact on <span class=SpellE>sensorimotor</span> function following <span class=SpellE>intracerebral</span> <span class=SpellE>haemorrhage</span> in mice, <span class=SpellE>Eur</span> J <span class=SpellE>Neurosci</span> 21:187-196, 2005</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/05/giuliani%20et%20al.,%20J%20Leuk%20Biol%2078,%20135,%202005.pdf"><b>Giuliani F, <span class=SpellE>Hader</span> W, Yong VW, <span class=SpellE>Minocycline</span> attenuates both T cell and microglia activity to impair cytokine production in T cell - microglia interaction, J <span class=SpellE>Leuk</span> <span class=SpellE>Biol</span> 78:135-143, 2005</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'>Giuliani F, Fu S, Metz LM, <b>Yong VW</b>,&nbsp; Effective combination of <span class=SpellE>minocycline</span> and interferon-² in a model of multiple sclerosis, J <span class=SpellE>Neuroimmunol</span> 165:83-91, 2005<o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/05/Weaver%20A.,%20et%20al.,%20FASEB%20J%20%2019,%201668,%202005.pdf"><b>Weaver A, <span class=SpellE>Goncalves</span> <span class=SpellE>da</span> Silva A, <span class=SpellE>Nuttall</span> RK, Edwards DR, Shapiro SD, <span class=SpellE>Rivest</span> S, Yong VW, An elevated matrix metalloproteinase in experimental autoimmune encephalomyelitis is protective by affecting Th1/Th2 polarization, FASEB J 19:1668-1670, 2005</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/05/Yong,%20Nature%20Rev%20Neurosci%206,%20931,%202005.pdf"><b>Yong VW, <span class=SpellE>Metalloproteinases</span>: Mediators of pathology and regeneration in the CNS, Nature Reviews <span class=SpellE>Neurosci</span> 6:931-944, 2005</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/05/zhang%20et%20al.,%20carcinogenesis,%2026,%202069,%202005%20on%20MT2-mmp.pdf"><b>Zhou Y, Zhang J, Liu Q, Bell R, <span class=SpellE>Muruve</span> DA, Forsyth P, <span class=SpellE>Arcellana-Panlilio</span> M, Robbins S, Yong VW, The <span class=SpellE>chemokine</span> GRO-± (CXCL1) confers increased <span class=SpellE>tumorigenicity</span> to <span class=SpellE>glioma</span> cells, Carcinogenesis 26: 2058</b></a><a href="pdf/05/zhang%20et%20al.,%20carcinogenesis,%2026,%202069,%202005%20on%20MT2-mmp.pdf"><b>-2068, 2005</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'>Zhang J, <span class=SpellE>Sarkar</span> S, <b>Yong VW</b>, The <span class=SpellE>chemokine</span> <span class=SpellE>stromal</span> cell derived factor-1 (CXCL12) promotes <span class=SpellE>glioma</span> invasiveness through MT2-matrix<o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'>metalloproteinase, Carcinogenesis 26:2069-2077, 2005<o:p></o:p></span></p> <h1><span style='font-family:"Verdana","sans-serif";mso-fareast-font-family: "Times New Roman";color:#003366'>2004<o:p></o:p></span></h1> <p><b><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'>Yong VW</span></b><span style='font-size:8.5pt;font-family: "Verdana","sans-serif";color:#003366'>, Prospects for <span class=SpellE>Neuroprotection</span> in multiple sclerosis, Frontiers <span class=SpellE>Biosci</span> 9:864-872, 2004<o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/04/Tsutsui%20et%20al.,%20JNeurosci%2024,%201521,%20%202004.pdf"><span class=SpellE><b>Tsutsui</b></span><b> S, <span class=SpellE>Schnermann</span> J, <span class=SpellE>Noorbakhsh</span> F, Yong VW, Warren K, Power C, A1 Adenosine receptor <span class=SpellE>upregulation</span> and activation attenuates <span class=SpellE>neuroinflammation</span> and <span class=SpellE>demyelination</span> in a model of multiple sclerosis, J <span class=SpellE>Neurosci</span> 24:1521-1529, 2004</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/04/Metz,%20et%20al.,%20Annals%20of%20Neurology%2055,%20756,%202004.pdf"><b>Metz LM, Zhang Y, <span class=SpellE>Yeung</span> M, <span class=SpellE>Patry</span> DG, Bell RB, <span class=SpellE>Stoian</span> CA, Yong VW, Patten SB, <span class=SpellE>Duquette</span> P, <span class=SpellE>Antel</span> JP, Mitchell JR, <span class=SpellE>Minocycline</span> Reduces Gadolinium-enhancing MRI Lesions in Multiple Sclerosis, Ann <span class=SpellE>Neurol</span> 55:756, 2004</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/04/Liberto%20et%20al.,%20JNChem%2089,%201092,%202004.pdf"><span class=SpellE><b>Liberto</b></span><b> CM, Albrecht PJ, <span class=SpellE>Herx</span> LM, Yong VW, <span class=SpellE>Levison</span> SW, Pro-regenerative properties of cytokine stimulated <span class=SpellE>astrocytes</span>, J <span class=SpellE>Neurochem</span> 89:1092-1100, 2004</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/04/Larsen%20and%20Yong,%20MMP-12%20OL,%20J%20Neurosci%2024,%207597,%202004.pdf"><b>Larsen P, Yong VW, The expression of matrix metalloproteinase-12 by <span class=SpellE>oligodendrocytes</span> regulates their maturation and morphological differentiation, J <span class=SpellE>Neurosci</span> 24:7597-7603, 2004</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/04/Antony%20et%20al.,%20Nature%20Neurosci%207,%201088,%202004.pdf"><b>Antony JM, van <span class=SpellE>Marle</span> G, <span class=SpellE>Opii</span> W, Butterfield DA, Mallet F, Yong VW, Wallace JL, Deacon RM, Warren K and Power C, Human endogenous retrovirus glycoprotein-mediated induction of <span class=SpellE>redox</span> reactants causes <span class=SpellE>oligodendrocyte</span> death and <span class=SpellE>demyelination</span>, Nature <span class=SpellE>Neurosci</span> 7:1088-1095, 2004</b></a><o:p></o:p></span></p> <p><span style='font-size:8.5pt;font-family:"Verdana","sans-serif"; color:#003366'><a href="pdf/04/Yong%20et%20al.%20minocycline%20Lancet%20Neurol%20review,%20Lancet%20Neurol%20.pdf"><b>Yong VW, Wells J, Giuliani F, <span class=SpellE>Casha</span> S, Power C, Metz LM, The promise of <span class=SpellE>minocycline</span> in neurology, Lancet Neurology 3:744-751, 2004</b></a><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:1;mso-yfti-lastrow:yes'> <td width=149 style='width:111.75pt;padding:0in 0in 0in 0in'></td> <td width="3%" style='width:3.0%;padding:0in 0in 0in 0in'></td> <td style='padding:0in 0in 0in 0in'></td> </tr> </table> <p class=MsoNormal><span style='mso-fareast-font-family:"Times New Roman"; color:windowtext'><o:p>&nbsp;</o:p></span></p> </div> </body> </html>